New York City-based Synergy Pharmaceuticals submitted a supplemental New Drug Application for Trulance. Here’s what you should know. 1. Trulance was FDA approved in adults with chronic idiopathic ...
Synergy Pharmaceuticals (SGYP +0.7%) files a supplemental New Drug Application (sNDA) with the FDA seeking approval of TRULANCE (plecanatide) to treat adults with irritable bowel syndrome with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback